Skip to main content

Saudi Central Bank

Bank

Position in NBIX — Neurocrine Biosciences Inc

CIK 1918181 Riyadh, T0

Position in NBIX

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$1,124,835
+$640,032 QoQ
Shares Held
6,674
+81.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#384
of 768 holders
Holding Since
Mar 2025
3 quarters on record

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Saudi Central Bank holds $4,736,097 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (23.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
6,674 $1,124,835

All Filings in NBIX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,124,835 6,674
2026-03-31 $484,803 3,680
2025-03-31 $4,424 40